VRTX
Vertex Pharmaceuticals Incorporated
HealthcareKey Metrics
Factor Lens
Seasonal Performance
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
Vertex Pharmaceuticals is a global biotechnology company focused on discovering, developing, and commercializing innovative medicines by combining transformative advances in human… disease understanding and therapeutic science. The company has approved medicines for cystic fibrosis (CF), sickle cell disease (SCD), transfusion-dependent beta thalassemia (TDT), and acute pain. For CF, Vertex markets five CFTR modulator therapies: ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor), SYMDEKO/SYMKEVI (tezacaftor/ivacaftor), ORKAMBI (lumacaftor/ivacaftor), and KALYDECO (ivacaftor). For SCD and TDT, Vertex offers CASGEVY (exagamglogene autotemcel), a CRISPR/Cas9-based gene-editing therapy. For acute pain, the company launched JOURNAVX (suzetrigine), a first-in-class NaV1.8 pain signal inhibitor. The company's mid- and late-stage clinical pipeline includes five pivotal programs: povetacicept for IgA nephropathy and primary membranous nephropathy, inaxaplin for APOL1-mediated kidney disease, suzetrigine for diabetic peripheral neuropathy, and zimislecel for type 1 diabetes. The company also has earlier-stage programs in autosomal dominant polycystic kidney disease, myotonic dystrophy type 1, and generalized myasthenia gravis. Vertex commercializes products primarily through specialty pharmacies and specialty distributors globally, with direct marketing to healthcare professionals. The company is dedicated to ensuring broad access to therapies through reimbursement arrangements and patient support programs.
- Name
- Vertex Pharmaceuticals Incorporated
- Industry
- Drug Manufacturers - General
- CEO
- Reshma Kewalramani · Chief Executive Officer and President
- Employees
- —
- IPO Date
- 2020-04-24
- Phone
- (617) 341-6100
- Address
- 50 Northern Avenue, Boston, MA 02210
- Website
- —
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| Nia Tatsis | Executive Vice President | — |
| Amit Sachdev | Executive Vice President, Chief Commercial Officer | — |
| Carmen Bozic | Chief Medical Officer | — |
| Jeffrey M. Leiden | Executive Chairman | — |
| Reshma Kewalramani | Chief Executive Officer and President | — |
Latest News
- 2026-04-24
- 2026-04-24
- 2026-04-23
- 2026-04-21
- 2026-04-20
- 2026-04-20
- 2026-04-19
- 2026-04-17